Vertex Pharmaceuticals Incorporated entered the industry of Commercial Medical Research in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Eric Bell by calling (617) 444-6100 during business hours. You can also write to the business’ Branch at 200 Sidney St, Cambridge, Massachusetts MA 02139. You can also visit the company’s website at investors.vrtx.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Vertex Pharmaceuticals Incorporated |
| Representative: | Eric Bell |
| Place of Business: | 200 Sidney St, Cambridge, MA 02139 |
| Contact Number: | (617) 444-6100 |
| Website: | investors.vrtx.com |
| Type of Service: | Commercial Medical Research |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Branch |
| Market Type: | B2B (Business to Business) |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Vertex Pharmaceuticals Incorporated is a company operating from Middlesex, Massachusetts providing professional Commercial Medical Research and relevant B2B variables. It was founded in 0 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Vertex Pharmaceuticals Incorporated has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Eric Bell at (617) 444-6100 for related queries, or to locate its Branch using the coordinates 42.358058,-71.105001.
The Branch can also be found at the street address 200 Sidney St in Cambridge, Massachusetts 02139 and can be engaged online through the company website at investors.vrtx.com, the company Twitter , and Facebook page .